SG11201703415QA - PROPHYLACTIC OR THERAPEUTIC AGENT FOR PEPTIC ULCER, FOOD ADDITIVE FOR PROPHYLACTIC OR THERAPEUTIC USE, iNOS EXPRESSION INHIBITOR AND COX-2 EXPRESSION INHIBITOR - Google Patents
PROPHYLACTIC OR THERAPEUTIC AGENT FOR PEPTIC ULCER, FOOD ADDITIVE FOR PROPHYLACTIC OR THERAPEUTIC USE, iNOS EXPRESSION INHIBITOR AND COX-2 EXPRESSION INHIBITORInfo
- Publication number
- SG11201703415QA SG11201703415QA SG11201703415QA SG11201703415QA SG11201703415QA SG 11201703415Q A SG11201703415Q A SG 11201703415QA SG 11201703415Q A SG11201703415Q A SG 11201703415QA SG 11201703415Q A SG11201703415Q A SG 11201703415QA SG 11201703415Q A SG11201703415Q A SG 11201703415QA
- Authority
- SG
- Singapore
- Prior art keywords
- prophylactic
- expression inhibitor
- cox
- food additive
- peptic ulcer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/68—Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014227305 | 2014-11-07 | ||
JP2015079534A JP6476043B2 (en) | 2014-11-07 | 2015-04-08 | Preventive or therapeutic agent for peptic ulcer, and food additive for prevention or treatment |
PCT/JP2015/081378 WO2016072507A1 (en) | 2014-11-07 | 2015-11-06 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR PEPTIC ULCER, FOOD ADDITIVE FOR PROPHYLACTIC OR THERAPEUTIC USE, iNOS EXPRESSION INHIBITOR AND COX-2 EXPRESSION INHIBITOR |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201703415QA true SG11201703415QA (en) | 2017-05-30 |
Family
ID=56071221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201703415QA SG11201703415QA (en) | 2014-11-07 | 2015-11-06 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR PEPTIC ULCER, FOOD ADDITIVE FOR PROPHYLACTIC OR THERAPEUTIC USE, iNOS EXPRESSION INHIBITOR AND COX-2 EXPRESSION INHIBITOR |
Country Status (4)
Country | Link |
---|---|
US (1) | US10117901B2 (en) |
JP (1) | JP6476043B2 (en) |
CN (1) | CN107405367A (en) |
SG (1) | SG11201703415QA (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190054127A1 (en) * | 2016-03-04 | 2019-02-21 | Euglena Co., Ltd. | Antiviral agent and antiviral food |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5084386A (en) * | 1989-03-31 | 1992-01-28 | Sri International | Production of beta-1,3-glucan in euglena |
JP2903318B2 (en) * | 1989-04-04 | 1999-06-07 | 日研フード株式会社 | Antioxidant stress substance |
JP2014027929A (en) * | 2012-07-06 | 2014-02-13 | Euglena Co Ltd | Biological feed additive |
JP2014098095A (en) * | 2012-11-14 | 2014-05-29 | National Institute Of Advanced Industrial & Technology | β-1,3-GLUCAN DERIVATIVE AND MANUFACTURING METHOD OF β-1,3-GLUCAN DERIVATIVE |
JP2014118374A (en) * | 2012-12-14 | 2014-06-30 | Euglena Co Ltd | Diabetes inhibitor |
MY173162A (en) | 2014-04-08 | 2019-12-31 | Euglena Co Ltd | Immune balance regulator |
-
2015
- 2015-04-08 JP JP2015079534A patent/JP6476043B2/en active Active
- 2015-11-06 CN CN201580060106.3A patent/CN107405367A/en active Pending
- 2015-11-06 SG SG11201703415QA patent/SG11201703415QA/en unknown
- 2015-11-06 US US15/524,522 patent/US10117901B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US10117901B2 (en) | 2018-11-06 |
JP2016094381A (en) | 2016-05-26 |
US20170319632A1 (en) | 2017-11-09 |
JP6476043B2 (en) | 2019-02-27 |
CN107405367A (en) | 2017-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1231513A1 (en) | Activin inhibitor response prediction and uses for treatment | |
AU2015342774B2 (en) | EZH2 inhibitors and uses thereof | |
EP3193608A4 (en) | Carm1 inhibitors and uses thereof | |
EP3151797A4 (en) | Methods and devices for treating the skin | |
EP3157338A4 (en) | Inoculants and methods for use thereof | |
EP3151438A4 (en) | Interference cancellation device and method | |
EP3139556A4 (en) | Interference cancellation device and method | |
EP3151495A4 (en) | Interference cancellation device and method | |
EP3218005A4 (en) | Glycan-interacting compounds and methods of use | |
EP3154972A4 (en) | Azamophinan derivatives and use thereof | |
EP3190970A4 (en) | Device and method for detection of haemoglobin and its complexes | |
PT3543240T (en) | Urat1 inhibitor and use thereof | |
EP3231451A4 (en) | Sanitary product and agent for treating sanitary product | |
EP3215157B8 (en) | Apilimod for use in the treatment of melanoma | |
EP3163932A4 (en) | Interference coordination method and device | |
ZA201701066B (en) | Pyridine derivatives and anti-mycobacterial use thereof | |
EP3122521A4 (en) | Leg augmentation systems and methods for use | |
EP3194377A4 (en) | Heterocycle substituted amino-pyridine compounds and methods of use thereof | |
SG11201605915WA (en) | Furo-3-carboxamide derivatives and methods of use | |
HK1250028A1 (en) | 2-phenyl-6-imidazolyl-pyridine-4-carboxamide derivatives and their use as eaat3 inhibitors | |
EP3124466A4 (en) | Triarylamine derivative and use of same | |
EP3167883A4 (en) | PPARy ACTIVATING AGENT | |
PL3052571T3 (en) | Temperature-resistant formulation containing natural coloring agent for food | |
EP3163945A4 (en) | Interference cancellation method and device | |
SG11201703415QA (en) | PROPHYLACTIC OR THERAPEUTIC AGENT FOR PEPTIC ULCER, FOOD ADDITIVE FOR PROPHYLACTIC OR THERAPEUTIC USE, iNOS EXPRESSION INHIBITOR AND COX-2 EXPRESSION INHIBITOR |